Patents by Inventor Rudolf Hausmann

Rudolf Hausmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INDUCIBLE CELL LYSIS SYSTEM
    Publication number: 20230407361
    Abstract: A programmable cell-lysis system and related compositions and methods are described, which facilitate expression and harvest of recombinant proteins from host cells. The programmable cell-lysis system comprises a host cell comprising a polynucleotide sequence encoding a cell lysis promoting polypeptide or peptide operably linked to an inducible promoter. The cell lysis systems can be configured to produce various heterologous polypeptides for different applications.
    Type: Application
    Filed: June 16, 2023
    Publication date: December 21, 2023
    Inventors: Lennart BIERMANN, Marius HENKEL, Lars LILGE, Rudolf HAUSMANN, Philippe PROCHASSON
  • Transmucosal administration system for a pharmaceutical drug
    Patent number: 10806703
    Abstract: The present invention relates to a transmucosal administration system to administer quinones, benzoquinones, and especially 1,4-benzoquinones, via the oromucosal route.
    Type: Grant
    Filed: January 20, 2012
    Date of Patent: October 20, 2020
    Assignees: LTS Lohmann Therapie-System AG, Santhera Pharmaceuticals (Schweitz) AG
    Inventors: Markus Krumme, Keith Jensen, Judith Dubach-Powell, Rudolf Hausmann
  • Transmucosal administration system for a pharmaceutical drug
    Patent number: 10716762
    Abstract: The present invention relates to a transmucosal administration system to administer quinones, benzoquinones, and especially 1,4-benzoquinones, via the oromucosal route.
    Type: Grant
    Filed: January 17, 2013
    Date of Patent: July 21, 2020
    Assignee: LTS Lohmann Therapie-Systeme AG
    Inventors: Markus Krumme, Keith Jensen, Judith Dubach-Powell, Rudolf Hausmann
  • Transmucosal Administration System for a Pharmaceutical Drug
    Publication number: 20190350872
    Abstract: The invention generally relates to transmucosal administration systems for administering quinones, benzoquinones, and especially 1,4-benzoquinones, via the oromucosal route. The present invention more specifically relates to methods of treatment for Duchenne Muscular Dystrophy that includes administering to a patient a dose in the form of one or more transmucosal administration systems.
    Type: Application
    Filed: August 5, 2019
    Publication date: November 21, 2019
    Inventors: Markus KRUMME, Keith JENSEN, Judith DUBACH-POWELL, Rudolf HAUSMANN
  • Transmucosal Administration System for a Pharmaceutical Drug
    Publication number: 20140377312
    Abstract: The present invention relates to a transmucosal administration system to administer quinones, benzoquinones, and especially 1,4-benzoquinones, via the oromucosal route.
    Type: Application
    Filed: January 17, 2013
    Publication date: December 25, 2014
    Applicant: Santhera Pharmaceuticals (Schweitz) AG
    Inventors: Markus Krumme, Keith Jensen, Judith Dubach-Powell, Rudolf Hausmann
  • Highly porous magnetic temporary fixed bed
    Patent number: 8303822
    Abstract: The present invention relates to a fixed bed, for example for the isolation and/or purification of components originating from a biological system, which fixed bed comprises magnetic beads and a magnetizable fabric arranged at least in part in the fixed bed, a fluidized bed-fixed bed, which comprises the fixed bed of the invention after application of an alternating magnetic field, and also to a process for the isolation and/or purification of components originating from a biological system.
    Type: Grant
    Filed: July 4, 2007
    Date of Patent: November 6, 2012
    Assignees: Universität Karlsruhe, Forschungszentrum Karlsruhe GmbH
    Inventors: Rudolf Hausmann, Matthias Franzreb
  • HIGHLY POROUS MAGNETIC TEMPORARY FIXED BED
    Publication number: 20100062509
    Abstract: The present invention relates to a fixed bed, for example for the isolation and/or purification of components originating from a biological system, which fixed bed comprises magnetic beads and a magnetizable fabric arranged at least in part in the fixed bed, a fluidized bed-fixed bed, which comprises the fixed bed of the invention after application of an alternating magnetic field, and also to a process for the isolation and/or purification of components originating from a biological system.
    Type: Application
    Filed: July 4, 2007
    Publication date: March 11, 2010
    Applicants: UNIVERSITÄT KARLSRUHE (TH), FORSCHUNGSZENTRUM KARLSRUHE GMBH
    Inventors: Rudolf Hausmann, Matthias Franzreb
  • TRANSMUCOSAL ADMINISTRATION OF 2,3-DIMETHOXY-5-METHYL-6-(10-HYDROXYDECYL)-1,4-BENZOQUINONE
    Publication number: 20090208425
    Abstract: Use of idebenone for the preparation of a medicament for transmucosal administration.
    Type: Application
    Filed: August 3, 2007
    Publication date: August 20, 2009
    Applicant: SANTHERA PHARMACEUTICALS (SCHWEIZ) AG
    Inventors: Judith Dubach-Powell, Rudolf Hausmann, Pierre Vankan